Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA(0),Tyr(3)]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

BACKGROUND: The bone marrow (BM) is a main organ at risk in Lu-177-PSMA-617 therapy of prostate cancer and Lu-177-Octreotate therapy of neuroendocrine tumours. BM dosimetry is challenging and time-consuming, as different sequential quantitative measurements must be combined. The BM absorbed dose fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosewisch, Astrid, Delker, Andreas, Tattenberg, Sebastian, Ilhan, Harun, Todica, Andrei, Brosch, Julia, Vomacka, Lena, Brunegraf, Anika, Gildehaus, Franz Josef, Ziegler, Sibylle, Bartenstein, Peter, Böning, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081875/
https://www.ncbi.nlm.nih.gov/pubmed/30076556
http://dx.doi.org/10.1186/s13550-018-0427-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081875/
https://www.ncbi.nlm.nih.gov/pubmed/30076556
http://dx.doi.org/10.1186/s13550-018-0427-z

Ejemplares similares